| Literature DB >> 29971166 |
Maíra Florentino Pessoa1, Helga C Muniz de Souza1, Alanna P Vasconcelos da Silva1, Rafaela Dos Santos Clemente1, Daniella Cunha Brandão1, Armèle Dornelas de Andrade1.
Abstract
Type II diabetes (TIIDM) is characterized by high levels of blood glucose followed by excessive insulin release so that the target cells become less sensitive, developing insulin resistance and maintaining hyperglycemic levels. Physical activity is the strongest element to prevent and to manage the TIIDM, and the majority of patients do not remain in regularly active levels, because the premature fatigue in these patients decreases the adherence to the training. Contrastingly, the whole body vibration (WBV) training may improve the glucose metabolism in diabetic patients, reducing the peripheral blood sugar, decreasing the physical discomfort and perceived exertion. Therefore, the purpose of the study was to determine the effect of an acute WBV session as therapy to promote fasting decreases in insulin levels in peripheral blood in TIIDM when compared to healthy elderly. For this, fifteen healthy elderly women and fourteen diabetic elderly women, all sedentary, were allocated in diabetic or control groups, and we made an acute whole body session composed of 10 bouts lasting 2 minutes each one, separated by a 30-second rest period. The WBV was executed in a triaxial platform MY3 Power Plate® at 35 hertz and has been chosen a peak-to-peak displacement of 4 millimeters. After the protocol, both groups decreased the glycemic levels and increased lactate production in relation to the basal levels and when compared diabetic and control, where the most important results have been shown in diabetic women. This study revealed that WBV training in TIIDM has had significant beneficial effects on the control of glucose levels, still in an acute session. So that, the complete training probably will show better results about glycemic control and this finding could be especially important when prescribing exercise for elderly who are unable or unwilling to use traditional loads or who show poor exercise compliance.Entities:
Year: 2018 PMID: 29971166 PMCID: PMC6008658 DOI: 10.1155/2018/3820615
Source DB: PubMed Journal: Rehabil Res Pract ISSN: 2090-2867
Figure 1Positioning in vibrating platform for both groups.
Figure 2Flowchart of the study volunteers.
Characteristics of control and diabetic groups at baseline.
| Variables | Control Group | Diabetes Group |
|
|---|---|---|---|
| ( | ( | ||
| Age (years) | 65.6 (63; 68.7) | 66.6 (63; 68.7) | 0.867 |
| Weight (kg) | 71.3 (60.2; 80.5) | 70.1 (64.5; 72.2) | 0.898 |
| Height (cm) | 162.6 (160.7; 165.5) | 163 (158.2; 167.7) | 0.858 |
| BMI (kg/m2) | 26.3 (22.5; 30.0) | 25.4 (24.8; 27.0) | 0.788 |
| HR pre (bpm) | 75 (69; 80) | 71 (66.5; 76) | 0.563 |
| Borg exertion pre | 0 (0; 0) | 0 (0; 0) | 1.00 |
| Glucose pre (mg/dL) | 97.5 (88.2; 105.2) | 125.5 (109.5; 151.7) |
|
| Lactate pre (mmol/L) | 1.6 (0.9; 2.9) | 1.3 (0.8; 2.0) | 0.149 |
BMI: body mass index; HR: heart rate; kg: kilogram; cm: centimeters; m2: square meter; bpm: beats per minute; mg/dL: milligram per decilitre; mmol/L: millimole per litre. Data have been shown as median and interquartile range; p < 0.05: control versusdiabetes.
Comparison between intra- and intergroups after intervention.
| Variables | Control Group | Diabetes Group |
|
|---|---|---|---|
| ( | ( | ||
| HR pre (bpm) | 75 (69; 80) | 71 (66.5; 76) | 0.563 |
| HR post (bpm) | 137 (119; 142)†† | 130 (123.5; 131.2)†† | 0.142 |
| HR variation (bpm) | 59 (41; 73.2) | 59.5 (39.5; 66.2) | 0.788 |
| Borg exertion pre | 0 (0; 0) | 0 (0; 0) | 1.00 |
| Borg exertion post | 4 (3; 5)†† | 4.5 (3; 6)†† |
|
| Borg exertion variation | 4 (3; 5) | 4.5 (3; 6) |
|
| Glucose pre (mg/dL) | 97.5 (88.2; 105.2) | 125.5 (109.5; 151.7) |
|
| Glucose post (mg/dL) | 84.5 (78.7; 94.5)†† | 92.5 (87.7; 101.2)†† | 0.130 |
| Glucose variation (mg/dL) | 10.5 (6.5; 16.7) | 26 (13.7; 45.2) |
|
| Lactate pre (mmol/L) | 1.6 (0.9; 2.9) | 1.3 (0.8; 2.0) | 0.149 |
| Lactate post (mmol/L) | 4.7 (4.3; 4.6)†† | 4.4 (4.3; 4.6)†† | 0.156 |
| Lactate variation (mmol/L) | 2.9 (2.5; 3.1) | 2.4 (2.0; 2.9) |
|
HR: heart rate bpm: beats per minute; mg/dL: milligram per decilitre; mmol/L: millimole per litre. Data were presented as median and interquartile range; p < 0.05: control versus diabetes; ††p < 0.05: pre versus post.